Share

Financial news - May 2023 - news published 76.217 - readings 1.014.062

Select company / Select period
Terna Rete Elettrica Nazionale S.p.A.

Terna Rete Elettrica Nazionale S.p.A.

Terna’s AGM approves financial statements for 2022 and total dividend for 2022 of 31.44 euro cents per share, up 8% on 2021

TERNA'S AGM APPROVES FINANCIAL STATEMENTS FOR 2022 AND TOTAL DIVIDEND FOR 2022 OF 31.44 EURO CENTS PER SHARE, UP 8% ON 2021 NEW BOARD OF DIRECTORS FOR THE 2023-2025 PERIOD APPOINTED IGOR DE BIASIO APPOINTED AS CHAIRMAN AGM approves financial statements for year ended 31 December 2022 and total dividend for 2022 of 31.44 euro cents per share, up 8% on 2021 (including interim di ...

Continue reading
09.05.2023
GLOBALFOUNDRIES Inc.

GLOBALFOUNDRIES Inc.

GlobalFoundries Announces Chief Financial Officer Transition and Names New Chief Business Officer

GlobalFoundries Announces Chief Financial Officer Transition and Names New Chief Business Officer May 9, 2023 Tim Stone to join GF as CFO and Niels Anderskouv joins as CBO to accelerate market leadership in differentiated technologies MALTA, N.Y., May 09, 2023 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ: GFS) (GF) today announced the appointment of two new senior executives to ...

Continue reading
09.05.2023
GLOBALFOUNDRIES Inc.

GLOBALFOUNDRIES Inc.

GlobalFoundries Announces Chief Financial Officer Transition and Names New Chief Business Office

May 9, 2023 Tim Stone to join GF as CFO and Niels Anderskouv joins as CBO to accelerate market leadership in differentiated technologies MALTA, N.Y.- May 9, 2023 - GlobalFoundries (NASDAQ: GFS) (GF) today announced the appointment of two new senior executives to its leadership team. Tim Stone has been appointed as the new Chief Financial Officer (CFO), taking over for David Re ...

Continue reading
09.05.2023
MoneyLion Inc.

MoneyLion Inc.

MoneyLion’s Q1 2023 Results Highlight Growth and Steady Path to Profitability - Form 8-K

MoneyLion's Q1 2023 Results Highlight Growth and Steady Path to Profitability GAAP Revenue of $94 million in the First Quarter of 2023, up 34% Year-over-Year Reached Quarterly GAAP Net Loss of $9 million and Positive Adjusted EBITDA of $7 million Total Customer Adds of 1.3 Million in Q1 2023; Total Customers up 102% Year-over-Year to 7.8 Million NEW YORK, NY, May 9, 2023 - Mon ...

Continue reading
09.05.2023
Inozyme Pharma Inc.

Inozyme Pharma Inc.

Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights - Form 8-K

Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights - Upcoming clinical and regulatory milestones remain on track with previous guidance - - Current cash, cash equivalents and short-term investments anticipated to fund cash flow requirements into the fourth quarter of 2024 - BOSTON, May 9, 2023 - Inozyme Pharma, Inc. (Nasdaq: INZY), a c ...

Continue reading
09.05.2023
Erste Group Bank AG

Erste Group Bank AG

PTA-DD: Managers' transactions announcement according to article 19 MAR

News-Service of the pressetext news agency Josefstädter Straße 44, 1080 Vienna, Austria, phone: +43 1 81140-0 Publication: 09.05.2023 14:30 Source: https://www.pressetext.com/news/20230509029 Keywords: Directors' Dealings / Eigengeschäfte von Führungskräften / Erste Group Bank AG Managers' transactions announcement according to article 19 MAR Erste Group Bank AG: Managers ...

Continue reading
09.05.2023
Nautilus Inc.

Nautilus Inc.

Bowflex Parent, Nautilus, Inc. to Announce Fourth Quarter and Full Year Fiscal 2023 Results on Tuesday, May 23, 2023

Print page << Back 05.09.23 Bowflex Parent, Nautilus, Inc. to Announce Fourth Quarter and Full Year Fiscal 2023 Results on Tuesday, May 23, 2023 VANCOUVER, Wash.--(BUSINESS WIRE)--May 9, 2023-- Bowflex parent, Nautilus, Inc. (NYSE: NLS) (the "Company") today announced that the Company will report its financial results for the fourth quarter and full year ended ...

Continue reading
09.05.2023
Jaguar Health Inc.

Jaguar Health Inc.

Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea

Primary endpoint based on patient reported outcomes from study expected in October 2023 With the completion of the PIPE financing of unregistered shares and 6-month lock up term, Jaguar has agreed, as described below, not to issue additional equity securities before October 22, 2023 - by which point the Company expects to have released top line data for the OnTarget trial SAN ...

Continue reading
09.05.2023